Caplin Point Laboratories Share Price

2,159.807.21 (0.34%)
Volume: 75,117

Closed
Last Updated On: 02 Jun, 2025, 03:44 PM IST

TECHNICALS
COMPARE

2,159.807.21 (0.34%)
Volume: 75,117

Stock Recommendations

Potential
Upside
1 Year
Target

STRONG BUY

Mean Recos by
2 Analysts

Strong Sell

Sell

Hold

Buy

Strong Buy

Unlock Potential Upside

Stock Reports Plus

/10

Stock Score

View Report

Earnings
Fundamentals
Relative Valuation
Risk
Price Momentum

No Rating (NR)

Negative

Neutral

Positive

Unlock Stock Score

Overview
News
Analysis
Recos
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Caplin Point share price insights

Quarterly Topline Performance
Company witnessed QoQ revenue decline of 0.74%, which is lowest in the last 3 years. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 9.17% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
Caplin Point Share Price Update
Caplin Point Laboratories Ltd. share price moved up by 0.34% from its previous close of Rs 2,152.60. Caplin Point Laboratories Ltd. stock last traded price is 2,159.80
Share Price Value
Today/Current/Last 2,159.802,158.30
Previous Day 2,152.602,152.40

Share Price	Value
Today/Current/Last	2,159.802,158.30
Previous Day	2,152.602,152.40

InsightsCaplin Point

Do you find these insights useful?

hate it
meh
love it

Key Metrics

PE Ratio

(x)

30.61

EPS - TTM

(₹)

70.55

MCap

(₹ Cr.)

16,335.67

Sectoral MCap Rank

PB Ratio

(x)

5.67

Div Yield

(%)

0.14

Face Value

(₹)

2.00

Beta

0.90

VWAP

(₹)

2,144.34

52W H/L

(₹)

2,641.00 / 1,225.00

Caplin Point Share Price Returns

1 Day	0.34%
1 Week	-0.96%
1 Month	14.55%
3 Months	18.51%
1 Year	67.39%
3 Years	185.71%
5 Years	550.05%

ET Stock ScreenersTop Score Companies

Check whether Caplin Point belongs to analysts' top-rated companies list?

View Stock Screeners

Caplin Point News & Analysis

View all Caplin Point Share News & Announcements

Caplin Point Share Recommendations

Recent Recos

STRONG BUY

Current

Mean Recos by 2 Analysts

Strong
SellSellHoldBuyStrong
Buy

Target₹957
OrganizationHDFC Securities
BUY

Target₹540
OrganizationICICI Direct
BUY

Analyst Trends

Ratings	Current	1 Week Ago	1 Month Ago	3 Months Ago
Strong Buy	1	1	1	1
Buy	1	1	1	1
Hold	-	-	-	-
Sell	-	-	-	-
Strong Sell	-	-	-	-
# Analysts	2	2	2	2

View all Stock Recommendations

Insights

Quarterly Topline Performance
Company witnessed QoQ revenue decline of 0.74%, which is lowest in the last 3 years. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 9.17% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

Quarterly \| Annual	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024
Total Income	528.19	524.32	503.87	477.52	470.51
Total Income Growth (%)	0.74	4.06	5.52	1.49	3.94
Total Expenses	351.43	346.87	335.10	323.11	324.39
Total Expenses Growth (%)	1.31	3.51	3.71	-0.39	5.62
EBIT	176.76	177.45	168.77	154.41	146.12
EBIT Growth (%)	-0.39	5.14	9.30	5.67	0.38
Profit after Tax (PAT)	142.57	138.96	130.80	123.97	121.59
PAT Growth (%)	2.60	6.24	5.51	1.96	3.75
EBIT Margin (%)	33.47	33.84	33.49	32.34	31.06
Net Profit Margin (%)	26.99	26.50	25.96	25.96	25.84
Basic EPS (₹)	18.75	18.28	17.22	16.32	16.01

Quarterly \| Annual	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024
Total Income	214.86	214.06	250.94	207.14	175.56
Total Income Growth (%)	0.37	-14.70	21.15	17.99	16.47
Total Expenses	104.66	113.85	116.26	110.44	88.63
Total Expenses Growth (%)	-8.07	-2.07	5.27	24.61	16.21
EBIT	110.20	100.21	134.68	96.70	86.93
EBIT Growth (%)	9.97	-25.59	39.28	11.24	16.75
Profit after Tax (PAT)	86.50	74.71	105.74	72.54	69.88
PAT Growth (%)	15.78	-29.35	45.77	3.81	26.02
EBIT Margin (%)	51.29	46.81	53.67	46.68	49.52
Net Profit Margin (%)	40.26	34.90	42.14	35.02	39.80
Basic EPS (₹)	11.37	9.83	13.92	9.55	9.20

Quarterly \| Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	2,033.90	1,761.04	1,522.71	1,308.16	1,084.83
Total Revenue Growth (%)	15.49	15.65	16.40	20.59	19.93
Total Expenses	1,357.11	1,196.88	1,071.44	922.34	771.21
Total Expenses Growth (%)	13.39	11.71	16.17	19.60	21.44
Profit after Tax (PAT)	536.31	457.09	376.26	299.84	242.27
PAT Growth (%)	17.33	21.48	25.49	23.76	12.68
Operating Profit Margin (%)	34.96	33.34	30.82	30.44	29.70
Net Profit Margin (%)	27.68	26.98	25.65	23.62	22.82
Basic EPS (₹)	70.57	60.19	49.62	39.61	32.03

Quarterly \| Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	887.00	730.93	627.61	584.61	501.30
Total Revenue Growth (%)	21.35	16.46	7.36	16.62	-15.58
Total Expenses	445.33	365.19	334.46	334.30	291.36
Total Expenses Growth (%)	21.94	9.19	0.05	14.74	-14.47
Profit after Tax (PAT)	339.49	283.71	234.26	187.87	156.22
PAT Growth (%)	19.66	21.11	24.69	20.26	-20.96
Operating Profit Margin (%)	58.71	58.52	55.47	47.41	43.52
Net Profit Margin (%)	45.12	45.38	44.31	35.57	32.36
Basic EPS (₹)	44.67	37.36	30.89	24.82	20.65

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	3,208.58	2,698.12	2,191.40	1,736.32	1,363.61
Total Assets Growth (%)	18.92	23.12	26.21	27.33	21.13
Total Liabilities	322.19	351.29	284.13	226.44	160.25
Total Liabilities Growth (%)	-8.28	23.64	25.48	41.31	-5.28
Total Equity	2,886.39	2,272.25	1,832.69	1,435.30	1,203.36
Total Equity Growth (%)	27.03	23.98	27.69	19.27	36.44
Current Ratio (x)	6.97	5.71	5.80	6.25	7.25
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.01
Contingent Liabilities	0.00	115.03	257.94	124.66	62.15

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	1,814.48	1,522.31	1,303.18	1,054.16	861.00
Total Assets Growth (%)	19.19	16.82	23.62	22.43	24.54
Total Liabilities	113.55	132.16	163.27	123.51	102.33
Total Liabilities Growth (%)	-14.08	-19.05	32.19	20.70	11.93
Total Equity	1,700.93	1,390.15	1,139.91	930.65	758.67
Total Equity Growth (%)	22.36	21.95	22.49	22.67	26.46
Current Ratio (x)	8.27	5.89	4.52	6.13	6.89
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.00
Contingent Liabilities	0.00	36.99	84.60	36.81	44.61

All figures in Rs Cr, unless mentioned otherwise

View Details

Insights

Increase in Cash from Investing
Company has used Rs 334.73 cr for investing activities which is an YoY increase of 4.59%. (Source: Consolidated Financials)

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	432.36	318.39	271.37	336.75	265.77
Net Cash used in Investing Activities	-334.73	-320.04	-217.58	-270.94	-5.36
Net Cash flow from Financing Activities	-38.32	-38.07	-28.17	-40.71	-23.98
Net Cash Flow	59.31	-39.01	26.80	25.01	236.20
Closing Cash & Cash Equivalent	198.02	138.55	177.56	460.73	456.96
Closing Cash & Cash Equivalent Growth (%)	42.92	-21.97	-61.46	0.82	106.99
Total Debt/ CFO (x)	0.00	0.00	0.01	0.00	0.06

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	195.87	111.01	157.10	230.97	294.65
Net Cash used in Investing Activities	-140.20	-118.94	-86.67	-237.18	16.28
Net Cash flow from Financing Activities	-38.10	-34.26	-30.42	-22.76	-3.46
Net Cash Flow	19.00	-41.38	41.01	-29.06	307.28
Closing Cash & Cash Equivalent	99.64	80.64	122.02	313.82	362.88
Closing Cash & Cash Equivalent Growth (%)	23.56	-33.91	-61.12	-13.52	552.58
Total Debt/ CFO (x)	0.00	0.00	0.00	0.00	0.00

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	18.81	20.39	20.83	21.27	20.43
Return on Capital Employed (%)	23.34	23.86	23.50	25.28	25.82
Return on Assets (%)	16.71	16.94	17.16	17.26	17.76
Interest Coverage Ratio (x)	1,218.62	792.79	637.23	619.17	198.29
Asset Turnover Ratio (x)	0.66	0.69	0.75	0.44	77.82
Price to Earnings (x)	28.41	21.93	12.05	17.21	12.63
Price to Book (x)	5.34	4.46	2.51	3.66	2.58
EV/EBITDA (x)	19.73	15.34	8.18	10.88	7.47
EBITDA Margin (%)	38.36	36.50	33.88	34.14	33.18

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	19.95	20.40	20.55	20.18	20.59
Return on Capital Employed (%)	25.76	26.07	25.36	26.21	26.81
Return on Assets (%)	18.71	18.63	17.97	17.82	18.14
Interest Coverage Ratio (x)	3,888.00	3,929.20	2,657.67	3,068.56	1,260.36
Asset Turnover Ratio (x)	0.45	0.44	0.45	0.55	56.06
Price to Earnings (x)	44.84	35.34	19.34	27.47	19.57
Price to Book (x)	8.95	7.20	3.97	5.54	4.03
EV/EBITDA (x)	32.16	24.91	13.35	17.52	11.57
EBITDA Margin (%)	62.00	62.85	60.33	52.29	48.17

Financial InsightsCaplin Point

Income (P&L)
Cash Flow

- Quarterly Topline Performance
  Company witnessed QoQ revenue decline of 0.74%, which is lowest in the last 3 years. (Source: Consolidated Financials)
- Employee & Interest Expense
  Company has spent less than 1% of its operating revenues towards interest expenses and 9.17% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
- Increase in Cash from Investing
  Company has used Rs 334.73 cr for investing activities which is an YoY increase of 4.59%. (Source: Consolidated Financials)

Do you find these insights useful?

hate it
meh
love it

Caplin Point Share Price Forecast

Price
Revenue
Earnings

Get multiple analysts’ prediction on Caplin Point
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL
Get multiple analysts’ prediction on Caplin Point
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL
Get multiple analysts’ prediction on Caplin Point
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL

Caplin Point Technicals

Buy / Sell Signals
Price Analysis
Pivot Levels & ATR
Chart

Stock doesn't have any Buy/Sell Signals.
41%
Positive Movement since
1st Jan 2005 on basis
58%
Negative Movement since
1st Jan 2005 on basis
Exclude
Global Meltdown - 1st Jan 2008 to 10th Nov 2008
Covid Crisis - 1st Feb 2020 to 31st Mar 2020
Pivot Levels
R1 R2 R3 PIVOT S1 S2 S3
Classic - - - - - - -
Average True Range
5 DAYS 14 DAYS 28 DAYS
ATR 86.08 85.79 89.85

	R1	R2	R3	PIVOT	S1	S2	S3
Classic	-	-	-	-	-	-	-

	5 DAYS	14 DAYS	28 DAYS
ATR	86.08	85.79	89.85

Caplin Point Peer Comparison

Caplin Point Stock Performance
Ratio Performance

CHART
TABLE

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Caplin Point Stock Performance	0.34	-0.96	14.55	18.51	67.39	185.71	550.05
Eris Lifesciences Stock Performance	-1.00	1.60	4.86	32.41	70.95	133.33	201.64
Alembic Pharma Stock Performance	-2.17	0.66	13.52	33.93	7.90	35.83	17.12
Jubilant Life Stock Performance	-0.35	4.30	28.97	29.58	70.00	197.37	139.96
Aarti Inds Stock Performance	0.30	0.54	10.31	25.17	-23.05	-36.39	-3.32
Add More

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Caplin Point	30.67	5.70	18.81	23.34	16.71	15.68	34.96	27.92	70.57	6.97	0.00	0.00
Eris Lifesciences	60.62	6.53	12.32	12.74	5.00	28.16	24.88	12.94	25.85	0.91	0.87	2.33
Alembic Pharma	33.50	3.77	11.23	14.40	7.50	7.74	11.57	8.71	29.68	1.69	0.23	13.59
Jubilant Life	22.18	2.98	13.41	8.13	6.58	5.83	11.91	11.56	52.99	1.65	0.39	2.27
Aarti Inds	51.54	3.04	5.90	7.59	2.97	6.11	7.99	4.55	9.13	0.84	0.68	3.05
Add More

Annual Ratios (%)

Choose from Peers

Blue Jet Healthcare
Natco Pharma
Neuland Labs
Granules India
Glenmark Life

Choose from Stocks

See All Parameters

Peers InsightsCaplin Point

Do you find these insights useful?

hate it
meh
love it

Caplin Point Shareholding Pattern

QOQ Change
Total Shareholdings

Loading...
Showing Caplin Point Shareholding as on Mar 2025
Category Mar 2025 Dec 2024 Sep 2024 Jun 2024
Promoters 70.56 70.56 70.56 70.56
Pledge 0.00 0.00 0.00 0.00
FII 5.72 4.86 3.71 3.38
DII 2.00 2.11 1.83 1.49
Mutual Funds 1.74 1.86 1.62 1.32
Others 21.72 22.47 23.90 24.57
Showing Shareholding as on Mar 2025
Category No. of Shares Percentage % Change QoQ
Promoters 5,36,32,982 70.56 % 0.00
Pledge 0 0.00 % 0.00
FII 43,55,704 5.72 % 0.86
DII 15,23,025 2.00 % -0.11
MF 13,23,903 1.74 % -0.12
Others 1,64,99,985 21.72 % -0.75

Category	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Promoters	70.56	70.56	70.56	70.56
Pledge	0.00	0.00	0.00	0.00
FII	5.72	4.86	3.71	3.38
DII	2.00	2.11	1.83	1.49
Mutual Funds	1.74	1.86	1.62	1.32
Others	21.72	22.47	23.90	24.57

Category	No. of Shares	Percentage	% Change QoQ
Promoters	5,36,32,982	70.56 %	0.00
Pledge	0	0.00 %	0.00
FII	43,55,704	5.72 %	0.86
DII	15,23,025	2.00 %	-0.11
MF	13,23,903	1.74 %	-0.12
Others	1,64,99,985	21.72 %	-0.75

Caplin Point MF Ownership

UTI Small Cap Direct-G
Equity: Small Cap
3.0
- 65.86
  Amount Invested (in Cr.)
- 1.55%
  % of AUM
- 6.33
  % Change (MoM basis)
UTI Aggressive Hybrid Direct-G
Hybrid: Aggressive Hybrid
4.0
- 45.25
  Amount Invested (in Cr.)
- 0.74%
  % of AUM
- 0.00
  % Change (MoM basis)
UTI Large & Mid Cap Direct-G
Equity: Large & MidCap
5.0
- 33.94
  Amount Invested (in Cr.)
- 0.78%
  % of AUM
- 0.00
  % Change (MoM basis)

MF Ownership as on 30 April 2025

View all Mutual Fund Schemes

Caplin Point Corporate Actions

Caplin Point Board Meeting/AGM
Caplin Point Dividends
Others

Meeting Date	Announced on	Purpose	Details
May 15, 2025	May 07, 2025	Board Meeting	Audited Results & Interim Dividend
Feb 07, 2025	Jan 31, 2025	Board Meeting	Quarterly Results
Nov 07, 2024	Oct 30, 2024	Board Meeting	Quarterly Results
Sep 30, 2024	Aug 07, 2024	AGM	Book closure from Sep 24, 2024 to Sep 30, 2024
Aug 07, 2024	Jul 31, 2024	Board Meeting	Quarterly Results & Final Dividend

Type	Dividend	Dividend per Share	Ex-Dividend Date	Announced on
Final	150%	3.0	May 30, 2025	May 15, 2025
Interim	150%	3.0	May 30, 2025	May 15, 2025
Final	125%	2.5	Sep 23, 2024	Aug 07, 2024
Interim	125%	2.5	May 31, 2024	May 16, 2024
Final	125%	2.5	Sep 14, 2023	Aug 07, 2023

All Types Ex-Date Record Date Announced on Details
Splits Oct 19, 2016 Oct 20, 2016 Aug 05, 2016 Split: Old FV10.0| New FV:2.0

All Types	Ex-Date	Record Date	Announced on	Details
Splits	Oct 19, 2016	Oct 20, 2016	Aug 05, 2016	Split: Old FV10.0\| New FV:2.0

About Caplin Point

Caplin Point Laboratories Ltd., incorporated in the year 1990, is a Small Cap company (having a market cap of Rs 16,362.28 Crore) operating in Pharmaceuticals sector. Caplin Point Laboratories Ltd. key Products/Revenue Segments include Pharmaceutical Products and Export Incentives for the year ending 31-Mar-2024. Show More

Executives
Auditors

CC
C C Paarthipan
Chairman
SG
Sridhar Ganesan
Managing Director
CK
C K Gariyali
Independent Director
DS
D Sathyanarayanan
Independent Director
RN
R Nagendran
Independent Director
SD
S Deenadayalan
Independent Director
DM
D Muralidharan
Chief Financial Officer
GV
G Venkatram
Company Secretary
Show More
Brahmayya & Co.
CNGSN & Associates LLP

Industry

Pharma - Indian

Key Indices Listed on

Nifty 500, BSE 500, BSE 250 SmallCap Index, + 15 more

Address

3rd Floor, Ashvich Towers,No.3, Developed Plots IndustrialEstate, Perungudi,Chennai (Madras), Tamil Nadu - 600096

Contact

[email protected]

www.caplinpoint.net

More Details

FAQs about Caplin Point share

1. What's Caplin Point share price today and what are Caplin Point share returns ?
Caplin Point share price is Rs 2,159.80 as on 02 Jun, 2025, 03:59 PM IST. Caplin Point share price is up by 0.34% based on previous share price of Rs. 2162.6. In last 1 Month, Caplin Point share price moved up by 14.55%.
2. What is the PE & PB ratio of Caplin Point?
The PE ratio of Caplin Point stands at 30.51, while the PB ratio is 5.67.
3. Who's the chairman of Caplin Point?
C C Paarthipan is the Chairman of Caplin Point
4. What is 52 week high/low of Caplin Point share price?
Caplin Point share price saw a 52 week high of Rs 2,641.00 and 52 week low of Rs 1,225.00.
5. What's the market capitalization of Caplin Point?
Market Capitalization of Caplin Point stock is Rs 16,335.67 Cr.
6. What is the recommendation for Caplin Point - Buy or Sell?
As per Refinitiv (erstwhile Thomson Reuters), overall mean recommendation by 2 analysts for Caplin Point stock is to Strong Buy. Recommendation breakup is as follows
- 1 analyst is recommending Strong Buy
- 1 analyst is recommending to Buy
7. What is the CAGR of Caplin Point?
The CAGR of Caplin Point is 11.15.
8. What are the Caplin Point quarterly results?
On Consoldiated basis, Caplin Point reported a total income and profit of Rs 528.19 Cr and Rs 142.57 respectively for quarter ending 2025-03-31. Total Income and profit for the year ending 2025-03-31 was Rs 2033.90 Cr and Rs 536.31 Cr.
9. Who are the peers for Caplin Point in Pharmaceuticals sector?
Top 10 Peers for Caplin Point are Jubilant Pharmova Ltd., Aarti Industries Ltd., Alembic Pharmaceuticals Ltd., Alivus Life Sciences Ltd., Neuland Laboratories Ltd., Blue Jet Healthcare Ltd, Granules India Ltd., Eris Lifesciences Ltd., Marksans Pharma Ltd. and Natco Pharma Ltd.
10. What are the returns for Caplin Point share?
Return Performance of Caplin Point Shares:
- 1 Week: Caplin Point share price moved down by 0.96%
- 1 Month: Caplin Point share price moved up by 14.55%
- 3 Month: Caplin Point share price moved up by 18.51%
11. Is Caplin Point giving dividend?
An equity Final dividend of Rs 3 per share was declared by Caplin Point Laboratories Ltd. on 15 May 2025. So, company has declared a dividend of 150% on face value of Rs 2 per share. The ex dividend date was 30 May 2025.
12. Who's the owner of Caplin Point?
Promoter, DII and FII owns 70.56, 2.11 and 4.86 shares of Caplin Point as on 31 Mar 2025
- There is no change in promoter holding from 31 Dec 2024 to 31 Mar 2025
- Domestic Institutional Investors holding have gone down from 2.11 (31 Dec 2024) to 2.0 (31 Mar 2025)
- Foreign Institutional Investors holding has gone up from 4.86 (31 Dec 2024) to 5.72 (31 Mar 2025)
- Other investor holding have gone down from 22.47 (31 Dec 2024) to 21.72 (31 Mar 2025)
13. How can I quickly analyze Caplin Point stock?
Caplin Point share can be quickly analyzed on following metrics:
- Stock's PE is 30.61
- Price to Book Ratio of 5.67

Trending in Markets

Top Gainers As on 03:59 PM | 02 Jun 2025

AstraZeneca9,336.50

1364.50 (17.12%)

CDSL1,682.90

153.21 (10.02%)

YES Bank23.28

1.81 (8.38%)

SterlingWilson Solar305.50

23.11 (8.18%)

Karur Vysya Bank239.66

17.97 (8.11%)

Top Losers As on 03:59 PM | 02 Jun 2025

Niva Bupa Health Ins83.11

-9.19 (-9.95%)

MMTC78.03

-7.74 (-9.03%)

ITI Ltd329.30

-17.31 (-5.00%)

Inox Wind Ltd.185.37

-9.63 (-4.94%)

Sai Life Science724.05

-32.91 (-4.35%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

BrowseCompanies:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

1 2 3 4 5 6 7 8 9

1 Day	0.27%
1 Week	-1.07%
1 Month	14.54%
3 Months	18.41%
1 Year	67.36%
3 Years	185.7%
5 Years	549.41%

ETPrime

Caplin Point Laboratories Share Price

Caplin Point share price insights

InsightsCaplin Point

Key Metrics

Key Metrics

Caplin Point Share Price Returns

ET Stock ScreenersTop Score Companies

Caplin Point News & Analysis

Caplin Point Share Recommendations

Recent Recos

Analyst Trends

Caplin Point Financials

Insights

Insights

Financial InsightsCaplin Point

Caplin Point Share Price Forecast

Get multiple analysts’ prediction on Caplin Point

Get multiple analysts’ prediction on Caplin Point

Get multiple analysts’ prediction on Caplin Point

Caplin Point Technicals

Pivot Levels

Average True Range

Caplin Point Peer Comparison

Ratio Performance

Peers InsightsCaplin Point

Caplin Point Shareholding Pattern

Caplin Point MF Ownership

UTI Small Cap Direct-G

UTI Aggressive Hybrid Direct-G

UTI Large & Mid Cap Direct-G

Caplin Point Corporate Actions

About Caplin Point

Executives

Auditors

More Details

FAQs about Caplin Point share

Trending in Markets

Top Gainers As on 03:59 PM | 02 Jun 2025

Top Losers As on 03:59 PM | 02 Jun 2025

Caplin Point Quick Links

Equity Quick Links

More from Markets